| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b58f981963f6d55d627139e778c4ef7b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-00 |
| filingDate |
2000-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dea937d0448fcc60edfe697371852b2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_475021ede6aadcca71c7ace57dba20a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6113905f84d648420f66adbc75b03983 |
| publicationDate |
2006-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7018648-B2 |
| titleOfInvention |
Transdermal device for administering testosterone or one of the derivatives thereof |
| abstract |
The invention relates to a self-adhesive transdermal device for the administration of testosterone and/or at least one of the derivatives thereof, comprising successively at least one support layer, a self-adhesive matrix layer and a detachable protective layer, whereby the matrix layer comprises at least one self-adhesive polymer, at least one formulating adjuvant for the matrix layer, at least one solvent chosen from the group made up of solvents of testosterone or the derivatives thereof and testosterone and/or at least one of the derivatives thereof in an oversaturated solution. The device has excellent testosterone permeation qualities and excellent cutaneous tolerance and adhesion qualities. The invention also relates to a method for the production of said device and the use thereof for a medicament, i.e. within the framework of a testosterone replacement therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009238861-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011028371-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2708239-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016256407-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8449907-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006210617-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015054608-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7556823-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007259027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007166365-A1 |
| priorityDate |
1999-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |